(EMAILWIRE.COM, April 14, 2020 ) The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic.


At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Live Cell Imaging Market. We are working diligently to help companies take rapid decisions by studying:

The impact of COVID-19 on the Live Cell Imaging Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market
The rapid shifts in the strategies of the Top 50 companies in the Live Cell Imaging Market
The shifting short-term priorities of the top 50 companies’ clients and their client's clients

You can request an in-depth analysis detailing the impact of COVID-19 on the Live Cell Imaging Market:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=163914483

According to the recent report  “Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023", published by MarketsandMarkets™, the global Live Cell Imaging Market size is projected to grow from USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9% from 2018 to 2023.

Browse in-depth TOC on “Live Cell Imaging Market”

88 – Tables
38 – Figures
147 – Pages

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163914483

The growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research are the major factors driving the growth of the global live cell imaging market. However, factors such as the high cost of high-content screening systems and the shortage of skilled professionals are expected to restrain the growth of this market during the forecast period.

The instruments segment accounted for the largest share of the market in 2018

On the basis of product and service, the global live cell imaging market is segmented into instruments, consumables, software, and services. In 2018, the instruments segment accounted for the largest share of the live cell imaging market. Factors such as the launch of new and advanced instruments, increasing incidence of diseases, and rising government initiatives and awareness programs for promoting cell-based research are the major factors driving the demand for live cell imaging instruments.

The academic & research institutes segment is expected to grow at the highest CAGR during the forecast period

On the basis of end user, the live cell imaging market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs). The academic & research institutes segment is expected to grow at a higher CAGR during the forecast period. The high growth in this segment can be attributed to the increasing focusing of academic and research institutes on strengthening their own drug discovery research programs coupled with rising government funding to support research and advancing scientific goals.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=163914483

North America dominated the live cell imaging market in 2018

North America is expected to dominate the live cell imaging market in 2018. The large share of the North America live cell imaging market can primarily be attributed to the availability of government funding for life science research, drug development regulations, advances in live cell imaging techniques, growth in the biotechnology and pharmaceutical industries, and the rising incidence of cancer.

 At a global level, companies such as Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), and NanoEnTek Inc. (Korea).

Browse Adjacent Markets: Cell Expansion Market Research Reports & Consulting